Navigation Links
ETEX Corporation Announces Distribution Agreement with Alphatec Spine

CAMBRIDGE, Mass., Nov. 5 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today a distribution agreement with Alphatec Spine, of Carlsbad, California. Alphatec Spine will market and sell ETEX's proprietary bone graft substitute portfolio on a non-exclusive basis in the United States.

(Logo: )

Initial sales and marketing efforts will be focused on EquivaBone®, ETEX's proprietary, certified osteoinductive hybrid bone graft. EquivaBone was the first FDA cleared hard-setting osteoinductive material and is the only osteoinductive bone graft substitute that provides a continuous nanocrystalline calcium phosphate scaffold.

Subsequent to regulatory clearance, Alphatec will market and sell ETEX's novel porous bone graft substitute, CarriGen®. CarriGen is a synthetic bone substitute that utilizes the same proprietary nanocrystalline calcium phosphate technology that is found in EquivaBone. CarriGen is currently under a 510(k) review with the F.D.A., and is not available for sale. As a pure synthetic, CarriGen is designed to set hard, and has compressive strength comparable to that of cancellous bone. CarriGen has high porosity which allows it to absorb saline and/or blood when mixed. Alphatec Spine expects to distribute CarriGen in the United States and Europe in the first half of 2010.

Brian Ennis, President and CEO of ETEX Corporation, comments: "We are quite impressed with Alphatec's team, technology platforms, and extraordinary growth in a challenging economic environment. The breadth and versatility in ETEX Corporation's rapidly expanding orthobiologic portfolio is extremely synergistic with Alphatec's market initiatives. We view this distribution agreement as the first phase of a partnership with substantial upside potential which may evolve into co-development efforts to create novel biologic / hardware solutions designed to optimize clinical outcomes in commonly occurring spinal conditions."

EquivaBone is indicated for use in posterolateral spine fusion, providing Alphatec Spine a novel biomaterial to complement their current spinal hardware focus. EquivaBone is a proprietary combination of osteoinductive Demineralized Bone Matrix (DBM) and ETEX's osteoconductive nanocrystalline calcium phosphate. ETEX is proud to offer the first combination product that is both moldable and injectable and sets hard once implanted. In addition, the osteoinductivity of the DBM is certified after sterilization, by lot, for the entirety of shelf life.

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit

About Alphatec Spine

Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq: ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, The Company also markets its spine products in Europe. In Asia, the Company markets a broad line of spine and orthopedic products through its subsidiary, Alphatec Pacific, Inc.

SOURCE ETEX Corporation

SOURCE ETEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Select Medical Holdings Corporation Announces Results for Third Quarter Ended September 30, 2009
2. Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation
3. Quantros Acquires MediQual(TM) From CareFusion Corporation
4. Dialysis Corporation of America Reports Third Quarter 2009 Results
5. Service Corporation International Announces Third Quarter 2009 Financial Results
6. NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)
7. Amerigroup Corporation to Present at the 18th Annual Credit Suisse Healthcare Conference on November 12
8. MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
9. Triple-S Management Corporation Reports Third Quarter 2009 Results
10. Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call
11. COMFORCE Corporation to Hold Conference Call to Discuss Third Quarter 2009 Results
Post Your Comments:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Volumes: Global Analysis (United States, China, Japan, Brazil, United ... to their offering. ... healthcare business planners, provides surgical procedure volume data in ... with an in-depth analysis of growth drivers and inhibitors, ...
Breaking Medicine Technology: